LD Hole, TH Larsen, KO Fossan, F Limé… - Cardiovascular …, 2014 - hero.epa.gov
Interventions to reduce the cardiotoxicity of doxorubicin are clinically relevant. Pharmacological preconditioning mimicking ischemic preconditioning has been …
LD Hole, TH Larsen, KO Fossan, F Limé, J Schjøtt - Cardiovasc Toxicol, 2014 - core.ac.uk
Interventions to reduce the cardiotoxicity of doxorubicin are clinically relevant. Pharmacological preconditioning mimicking ischemic preconditioning has been …
Interventions to reduce the cardiotoxicity of doxorubicin are clinically relevant. Pharmacological preconditioning mimicking ischemic preconditioning has been …
L Hole, T Larsen, K Fossan, F Limé… - Cardiovascular …, 2014 - search.ebscohost.com
Interventions to reduce the cardiotoxicity of doxorubicin are clinically relevant. Pharmacological preconditioning mimicking ischemic preconditioning has been …
LD Hole, TH Larsen, KO Fossan, F Limé… - Cardiovasc …, 2014 - researchgate.net
Interventions to reduce the cardiotoxicity of doxorubicin are clinically relevant. Pharmacological preconditioning mimicking ischemic preconditioning has been …
LD Hole, TH Larsen, KO Fossan, F Limé… - Cardiovascular …, 2014 - europepmc.org
Interventions to reduce the cardiotoxicity of doxorubicin are clinically relevant. Pharmacological preconditioning mimicking ischemic preconditioning has been …
Interventions to reduce the cardiotoxicity of doxorubicin are clinically relevant. Pharmacological preconditioning mimicking ischemic preconditioning has been …
LD Hole, TH Larsen, KO Fossan, F Limé, J Schjøtt - cyberleninka.org
Interventions to reduce the cardiotoxicity of doxorubicin are clinically relevant. Pharmacological preconditioning mimicking ischemic preconditioning has been …
LD Hole, TH Larsen, KO Fossan, F Limé… - Cardiovascular …, 2014 - infona.pl
Interventions to reduce the cardiotoxicity of doxorubicin are clinically relevant. Pharmacological preconditioning mimicking ischemic preconditioning has been …